These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Pyridothiadiazine derivatives as aldose reductase inhibitors having antioxidant activity. Zhu S, Zhang S, Hao X, Qin X, Parveen S, Yang S, Ma B, Zhu C. J Enzyme Inhib Med Chem; 2016 May 01; 31(sup1):126-130. PubMed ID: 27153454 [Abstract] [Full Text] [Related]
11. Synthesis and biological evaluation of 2,4-diamino-6-(arylaminomethyl)pyrido[2,3-d]pyrimidines as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase and as antiopportunistic infection and antitumor agents. Gangjee A, Adair OO, Queener SF. J Med Chem; 2003 Nov 06; 46(23):5074-82. PubMed ID: 14584957 [Abstract] [Full Text] [Related]
12. A diverse series of substituted benzenesulfonamides as aldose reductase inhibitors with antioxidant activity: design, synthesis, and in vitro activity. Alexiou P, Demopoulos VJ. J Med Chem; 2010 Nov 11; 53(21):7756-66. PubMed ID: 20936791 [Abstract] [Full Text] [Related]
17. Isoxazolo-[3,4-d]-pyridazin-7-(6H)-one as a potential substrate for new aldose reductase inhibitors. Costantino L, Rastelli G, Gamberini MC, Giovannoni MP, Dal Piaz V, Vianello P, Barlocco D. J Med Chem; 1999 Jun 03; 42(11):1894-900. PubMed ID: 10354397 [Abstract] [Full Text] [Related]